| Characteristics | Rheumatoid arthritis | p-value | |
| Present | Absent |
| |
| Age (mean ± SD), Years | 51.0 ± 14.8 | 51.2 ± 15.3 | 0.916 |
| Sex |
|
|
|
| -Females N (%) | 39 (78) | 39 (76.5) | 0.855 |
| -Males N (%) | 11 (22) | 12 (23.5) |
|
| Duration* (mean ± SD), Years | 9.84 ± 7.97 | NA |
|
| Comorbidity, N (%) | 34 (68) | NA |
|
| -Infections | 29 (58) |
|
|
| -PUD | 16 (32) |
|
|
| -Osteoarthris | 1 (2) |
|
|
| -Asthma | 1 (2) |
|
|
| -Cancer | 1 (2) |
|
|
| -Depression | 1 (2) |
|
|
| -Parkinson’s disease | 1 (2) |
|
|
| Treatment of RA, N (%) |
| NA |
|
| -Symptomatic treatment |
|
|
|
| Corticosteroids | 26 (52) |
|
|
| NSAIDs | 2 (4) |
|
|
| -Specific treatment |
|
|
|
| MTX | 24 (48) |
|
|
| HCQ | 5 (10) |
|
|
| AZT | 2 (4) |
|
|
| SSZ | 1 (2) |
|
|
| LEF | 1 (2) |
|
|
| -Without treatment | 18 (36) |
|
|